Logo image of AKZA.AS

AKZO NOBEL N.V. (AKZA.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:AKZA - NL0013267909 - Common Stock

58.48 EUR
-0.68 (-1.15%)
Last: 1/7/2026, 5:36:15 PM
Fundamental Rating

4

AKZA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 73 industry peers in the Chemicals industry. While AKZA is still in line with the averages on profitability rating, there are concerns on its financial health. AKZA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AKZA had positive earnings in the past year.
AKZA had a positive operating cash flow in the past year.
AKZA had positive earnings in each of the past 5 years.
Each year in the past 5 years AKZA had a positive operating cash flow.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

With a Return On Assets value of 0.42%, AKZA perfoms like the industry average, outperforming 42.47% of the companies in the same industry.
The Return On Equity of AKZA (1.48%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 3.70%, AKZA is in line with its industry, outperforming 52.05% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AKZA is in line with the industry average of 6.84%.
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROIC 3.7%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

AKZA has a Profit Margin of 0.56%. This is comparable to the rest of the industry: AKZA outperforms 43.84% of its industry peers.
In the last couple of years the Profit Margin of AKZA has declined.
The Operating Margin of AKZA (4.84%) is comparable to the rest of the industry.
AKZA's Operating Margin has been stable in the last couple of years.
AKZA has a Gross Margin (39.78%) which is comparable to the rest of the industry.
AKZA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AKZA is destroying value.
Compared to 1 year ago, AKZA has about the same amount of shares outstanding.
Compared to 5 years ago, AKZA has less shares outstanding
The debt/assets ratio for AKZA has been reduced compared to a year ago.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.07 indicates that AKZA is not a great score, but indicates only limited risk for bankruptcy at the moment.
AKZA has a Altman-Z score of 2.07. This is in the lower half of the industry: AKZA underperforms 60.27% of its industry peers.
The Debt to FCF ratio of AKZA is 10.17, which is on the high side as it means it would take AKZA, 10.17 years of fcf income to pay off all of its debts.
AKZA has a Debt to FCF ratio (10.17) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.93 indicates that AKZA is somewhat dependend on debt financing.
The Debt to Equity ratio of AKZA (0.93) is worse than 78.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Altman-Z 2.07
ROIC/WACC0.64
WACC5.76%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

AKZA has a Current Ratio of 1.25. This is a normal value and indicates that AKZA is financially healthy and should not expect problems in meeting its short term obligations.
AKZA's Current ratio of 1.25 is on the low side compared to the rest of the industry. AKZA is outperformed by 78.08% of its industry peers.
AKZA has a Quick Ratio of 1.25. This is a bad value and indicates that AKZA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.92, AKZA is doing worse than 61.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.92
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

AKZA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.93%.
AKZA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.44% yearly.
AKZA shows a decrease in Revenue. In the last year, the revenue decreased by -2.03%.
The Revenue has been growing slightly by 2.92% on average over the past years.
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%

3.2 Future

Based on estimates for the next years, AKZA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.67% on average per year.
Based on estimates for the next years, AKZA will show a small growth in Revenue. The Revenue will grow by 4.06% on average per year.
EPS Next Y3.31%
EPS Next 2Y8.12%
EPS Next 3Y8.87%
EPS Next 5Y9.67%
Revenue Next Year-3.31%
Revenue Next 2Y-2.08%
Revenue Next 3Y0.46%
Revenue Next 5Y4.06%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.07, AKZA is valued correctly.
Based on the Price/Earnings ratio, AKZA is valued a bit cheaper than the industry average as 76.71% of the companies are valued more expensively.
AKZA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.17, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 12.86 indicates a correct valuation of AKZA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AKZA indicates a somewhat cheap valuation: AKZA is cheaper than 76.71% of the companies listed in the same industry.
AKZA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.79.
Industry RankSector Rank
PE 16.07
Fwd PE 12.86
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

AKZA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AKZA is more expensive than 63.01% of the companies in the same industry.
AKZA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AKZA is cheaper than 72.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.02
EV/EBITDA 16.11
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AKZA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.85
PEG (5Y)3.62
EPS Next 2Y8.12%
EPS Next 3Y8.87%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.34%, AKZA has a reasonable but not impressive dividend return.
AKZA's Dividend Yield is a higher than the industry average which is at 2.59.
AKZA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.94.
Industry RankSector Rank
Dividend Yield 3.34%

5.2 History

The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

AKZA pays out 691.38% of its income as dividend. This is not a sustainable payout ratio.
DP691.38%
EPS Next 2Y8.12%
EPS Next 3Y8.87%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

AKZO NOBEL N.V.

AMS:AKZA (1/7/2026, 5:36:15 PM)

58.48

-0.68 (-1.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-22 2025-10-22/bmo
Earnings (Next)01-27 2026-01-27/amc
Inst Owners73.9%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap10.00B
Revenue(TTM)10.40B
Net Income(TTM)58.00M
Analysts76.52
Price Target70.25 (20.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.34%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP691.38%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.89%
Min EPS beat(2)-7.4%
Max EPS beat(2)-6.38%
EPS beat(4)0
Avg EPS beat(4)-11.39%
Min EPS beat(4)-27.6%
Max EPS beat(4)-4.18%
EPS beat(8)1
Avg EPS beat(8)-8.1%
EPS beat(12)2
Avg EPS beat(12)-11.74%
EPS beat(16)4
Avg EPS beat(16)-11.18%
Revenue beat(2)0
Avg Revenue beat(2)-3.03%
Min Revenue beat(2)-5.13%
Max Revenue beat(2)-0.93%
Revenue beat(4)1
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)1.79%
Revenue beat(8)1
Avg Revenue beat(8)-1.51%
Revenue beat(12)3
Avg Revenue beat(12)-1.43%
Revenue beat(16)3
Avg Revenue beat(16)-1.57%
PT rev (1m)-0.01%
PT rev (3m)-1.61%
EPS NQ rev (1m)-17.86%
EPS NQ rev (3m)-14.33%
EPS NY rev (1m)-1.03%
EPS NY rev (3m)-5.35%
Revenue NQ rev (1m)-1.34%
Revenue NQ rev (3m)-2.15%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 16.07
Fwd PE 12.86
P/S 0.96
P/FCF 19.02
P/OCF 11.78
P/B 2.54
P/tB 68.51
EV/EBITDA 16.11
EPS(TTM)3.64
EY6.22%
EPS(NY)4.55
Fwd EY7.78%
FCF(TTM)3.08
FCFY5.26%
OCF(TTM)4.96
OCFY8.49%
SpS60.83
BVpS22.98
TBVpS0.85
PEG (NY)4.85
PEG (5Y)3.62
Graham Number43.38
Profitability
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROCE 5.56%
ROIC 3.7%
ROICexc 4.33%
ROICexgc 8.48%
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
FCFM 5.06%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
ROICexc(3y)6.53%
ROICexc(5y)7.21%
ROICexgc(3y)12.06%
ROICexgc(5y)13.03%
ROCE(3y)9.71%
ROCE(5y)10.22%
ROICexgc growth 3Y-10.53%
ROICexgc growth 5Y-0.19%
ROICexc growth 3Y-9.99%
ROICexc growth 5Y-0.31%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Debt/EBITDA 4.17
Cap/Depr 86.36%
Cap/Sales 3.1%
Interest Coverage 2.86
Cash Conversion 96.7%
Profit Quality 906.9%
Current Ratio 1.25
Quick Ratio 0.92
Altman-Z 2.07
F-Score5
WACC5.76%
ROIC/WACC0.64
Cap/Depr(3y)80.65%
Cap/Depr(5y)79.09%
Cap/Sales(3y)2.74%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
EPS Next Y3.31%
EPS Next 2Y8.12%
EPS Next 3Y8.87%
EPS Next 5Y9.67%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%
Revenue Next Year-3.31%
Revenue Next 2Y-2.08%
Revenue Next 3Y0.46%
Revenue Next 5Y4.06%
EBIT growth 1Y-49.8%
EBIT growth 3Y-6.39%
EBIT growth 5Y1.75%
EBIT Next Year30.04%
EBIT Next 3Y15.63%
EBIT Next 5Y9.68%
FCF growth 1Y-8.04%
FCF growth 3Y4.63%
FCF growth 5YN/A
OCF growth 1Y1.07%
OCF growth 3Y3.41%
OCF growth 5Y96.16%

AKZO NOBEL N.V. / AKZA.AS FAQ

What is the ChartMill fundamental rating of AKZO NOBEL N.V. (AKZA.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKZA.AS.


What is the valuation status for AKZA stock?

ChartMill assigns a valuation rating of 4 / 10 to AKZO NOBEL N.V. (AKZA.AS). This can be considered as Fairly Valued.


What is the profitability of AKZA stock?

AKZO NOBEL N.V. (AKZA.AS) has a profitability rating of 4 / 10.


What is the financial health of AKZO NOBEL N.V. (AKZA.AS) stock?

The financial health rating of AKZO NOBEL N.V. (AKZA.AS) is 3 / 10.


What is the earnings growth outlook for AKZO NOBEL N.V.?

The Earnings per Share (EPS) of AKZO NOBEL N.V. (AKZA.AS) is expected to grow by 3.31% in the next year.